ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 18 filers reported holding ENLIVEX THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lee Capital Holdings LLC | 11,805 | $46,482 | 0.07% |
| Susquehanna International Group Ltd. | 18,887 | $72,073 | 0.03% |
| Compagnie Lombard Odier SCmA | 50,000 | $190,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $50,700 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 647 | $2,547 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11,746 | $46,250 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 13,499 | $52,646 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,420 | $40 | 0.00% |